Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series

Demisse, R; Damle, N; Kim, E; Gong, J; Fakih, M; Eng, C; Oesterich, L; McKenny, M; Ji, JR; Liu, J; Louie, R; Tam, K; Gholami, S; Halabi, W; Monjazeb, A; Dayyani, F; Cho, M

Demisse, R (corresponding author), UC Davis Comprehens Canc Ctr, 4501 X St, Sacramento, CA 95817 USA.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020; 18 (7): 798

Abstract

Treatment options for locally advanced rectal cancer have continued to consist largely of chemotherapy, chemoradiation, and/or surgical resection. For......

Full Text Link